| Sulfonamide hypersensitivity syndrome |
|---|
Sulfonamide hypersensitivity syndrome is similar to anticonvulsant hypersensitivity syndrome, but the onset is often sooner in the treatment course, generally after 7–14 days of therapy. [1]: 118–9
It is considered immune-mediated. [2]
See also
References
- ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0721629210.
- ^ Cribb AE, Pohl LR, Spielberg SP, Leeder JS (August 1997). "Patients with delayed-onset sulfonamide hypersensitivity reactions have antibodies recognizing endoplasmic reticulum luminal proteins". J. Pharmacol. Exp. Ther. 282 (2): 1064–71. PMID 9262376.
External links
 | This cutaneous condition article is a stub. You can help Wikipedia by expanding it. |